0001437749-21-013628.txt : 20210528
0001437749-21-013628.hdr.sgml : 20210528
20210528083135
ACCESSION NUMBER: 0001437749-21-013628
CONFORMED SUBMISSION TYPE: 5/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20171231
FILED AS OF DATE: 20210528
DATE AS OF CHANGE: 20210528
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Aubrey de Lavenu Harold Andre
CENTRAL INDEX KEY: 0001737899
FILING VALUES:
FORM TYPE: 5/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-55557
FILM NUMBER: 21976291
MAIL ADDRESS:
STREET 1: APT 627 VALE DO LOBO
CITY: ALMANCIL
STATE: S1
ZIP: 8135-034
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CEN BIOTECH INC
CENTRAL INDEX KEY: 0001653821
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: Z4
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 300-3295 QUALITY WAY
CITY: WINDSOR
STATE: A6
ZIP: N8T 3R9
BUSINESS PHONE: 226-344-0660
MAIL ADDRESS:
STREET 1: 300-3295 QUALITY WAY
CITY: WINDSOR
STATE: A6
ZIP: N8T 3R9
5/A
1
rdgdoc.xml
FORM 5/A
X0306
5/A
2017-12-31
2021-04-26
0
1
0001653821
CEN BIOTECH INC
CENBF
0001737899
Aubrey de Lavenu Harold Andre
300-3295 QUALITY WAY
WINDSOR, ONTARIO, CANADA
A6
N8T 3R9
ONTARIO, CANADA
1
Common Stock
2017-11-30
4
A
0
L
20000
0
A
689571
D
20,000 shares of common stock of issuer were granted by the issuer on November 30, 2017, pursuant to a restricted stock agreement pursuant to the issuer's equity compensation plan and the issuance was approved by the issuer's full board of directors.
689,571 shares were beneficially owned by the reporting person of which 656,250 shares were issuable upon conversion of convertible notes held by the reporting person at 12/31/2017.
The reporting person has served as a member of the board of directors of the issuer since July 2017 and was appointed to serve as a vice president of the issuer on April 2, 2021.
/s/ Harold Aubrey de Lavenu
2021-05-28